Andrea Bille
Overview
Explore the profile of Andrea Bille including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
1292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waller D, Bilancia R, Ventura L, Tenconi S, Socci L, Bille A
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075572
Background/objectives: The published report of the MARS2 trial suggested that the addition of extended pleurectomy/decortication to chemotherapy for pleural mesothelioma was harmful. Thus, the report goes on, all disease should...
2.
The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes
Torricelli F, Spada F, Bishop C, Todd K, Nonaka D, Petrov N, et al.
J Transl Med
. 2025 Feb;
23(1):208.
PMID: 39980060
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy with limited therapeutic options. To improve patients management and treatment, more precise stratification strategies are needed. This study aimed...
3.
Patel A, Josephides E, Bilkhu R, Bosco P, Lucchese G, Bille A
J Thorac Dis
. 2025 Feb;
17(1):299-307.
PMID: 39975751
Background: Thymic epithelial tumors (TETs) represent the predominant primary malignancy of the anterior mediastinum, often necessitating complex surgical interventions due to their invasive nature. The prognosis of advanced TET relies...
4.
Josephides E, Smith D, Bille A, Patel A, Rush H, Dunn R, et al.
Clin Lung Cancer
. 2025 Feb;
PMID: 39915192
Background: Immune checkpoint inhibitors have improved survival in patients with non-small cell lung cancer (NSCLC). Whilst PD-L1 expression is a useful predictive biomarker, data on concordance of expression between primary...
5.
Ricciardi S, Patel A, Fegatelli D, Volpi S, Femia F, Petrella L, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797168
: Significant intraoperative and postoperative blood loss are rare but possibly life-threatening complications after lung resection surgery either during open or minimally invasive procedures. Microporous Polysaccharide Haemospheres (ARISTA™AH) have demonstrated...
6.
Chan P, Patel A, Lucchese G, Bille A
J Cardiothorac Surg
. 2025 Jan;
20(1):40.
PMID: 39773229
Introduction: Thymomas and thymic carcinomas are rare anterior mediastinal tumours, accounting for 0.2-1.5% of all cancers. Surgical resection is key to treatment, though invasion of surrounding structures like great vessels...
7.
Obajdin J, Larcombe-Young D, Glover M, Kausar F, Hull C, Flaherty K, et al.
Cell Rep Med
. 2024 Nov;
5(11):101827.
PMID: 39566469
NKG2D ligands (NKG2DLs) are broadly expressed in cancer. To target these, we describe an adaptor chimeric antigen receptor (CAR) termed NKG2D/Dap10-12. Herein, T cells are engineered to co-express NKG2D with...
8.
Patel A, Smith A, Ruffini E, Bille A
Eur J Cardiothorac Surg
. 2024 Sep;
66(4.
PMID: 39325852
Objectives: Minimally invasive thymectomy is an accepted approach for early-stage thymic epithelial neoplasia, reducing pain and length of stay compared with open surgery. In this study, we compare robotic and...
9.
Josephides E, Dunn R, Henry A, Pilling J, Harrison-Phipps K, Patel A, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272916
Background: Stage IIIA-N2 non-small cell lung cancer (NSCLC) poses a significant clinical challenge, with low survival rates despite advances in therapy. The lack of a standardised treatment approach complicates patient...
10.
Kindler H, Rosenthal A, Giroux D, Nowak A, Bille A, Gill R, et al.
J Thorac Oncol
. 2024 Aug;
19(11):1564-1577.
PMID: 39181447
Introduction: The International Association for the Study of Lung Cancer developed a global multicenter database to propose evidence-based revisions for the ninth edition of the TNM classification of pleural mesothelioma...